Kvantify Taps Gefion AI Supercomputer to Scale Quantum Chemistry Simulations for Drug Discovery
As reported by The Quantum Insider, Kvantify, a Denmark-based quantum software firm focused on chemistry and drug discovery, has become the first dedicated quantum company to deploy the Gefion AI supercomputer for simulating quantum computing workflows at scale. While Gefion was originally built for large-scale AI workloads, its GPU-accelerated architecture is being repurposed by Kvantify to run proprietary algorithms for molecular modeling and enzyme engineering.
The company’s simulation platform is designed to emulate quantum processors in order to study chemically relevant systems—such as penicillin—using hundreds of qubits, far beyond the capabilities of current quantum hardware. According to Kvantify's Head of Engineering Casper Kirkegaard, Gefion’s infrastructure allows them to model future quantum systems with exaflop-level performance.
As for the role of AI infrastructure in cross-disciplinary scientific computing, Gefion is serving as a high-performance backbone not only for machine learning, but also for quantum chemistry, materials modeling, and next-generation HPC workflows.
Gefion, launched in late 2024 with an initial investment of DKK 700 million (approximately $101 million USD) from the Novo Nordisk Foundation and EIFO, is Denmark’s first AI supercomputer and part of a national strategy to strengthen competitiveness in life sciences and quantum technologies. It runs on 1,528 NVIDIA H100 GPUs and is hosted on 100% renewable energy by Digital Realty, with infrastructure developed in collaboration with NVIDIA and operated by the Danish Centre for AI Innovation (DCAI).
Topics: AI & Digital
